Skip to main content

Table 4 Relations of rs3746444 A > G genotypic frequencies to clinical data

From: Pre-microRNAs single nucleotide variants (rs3746444 A > G and rs2910164 C > G) increase the risk of ischemic stroke in the Egyptian population: a case–control study

Parameters

rs3746444 A > G

rs3746444 A > G

GG

N (%)

AG

N (%)

AA

N (%)

p Value*

GG + AG

N (%)

AA

N (%)

p Value*

Age (years)

≤ 40 Years

4 (8.3)

3 (21.4)

4 (10.5)

0.382

7 (11.3)

4 (10.5)

1

> 40 Years

44 (91.7)

11 (78.6)

34 (89.5)

55 (88.7)

34 (89.5)

Mean ± SD

56.50 ± 10.86

51.43 ± 10.99

54.47 ± 10.90

0.272

55.35  ± 11.01

54.47  ± 10.90

0.541

Gender

Males

31 (64.6)

11 (78.6)

23 (60.5)

0.528

42 (67.7)

23 (60.5)

0.463

Females

17 (35.4)

3 (21.4)

15 (39.5)

20 (32.3)

15 (39.5)

Risk factors of stroke

Smoker

20 (41.7)

6 (42.9)

15 (39.5)

0.968

26 (41.9)

15 (39.5)

0.808

DM

25 (52.1)

4 (28.6)

20 (52.6)

0.257

29 (46.8)

20 (52.6)

0.570

HTN

35 (72.9)

5 (35.7)

21 (55.3)

0.028*

40 (64.5)

21 (55.3)

0.357

Hyperlipidemia

12 (25)

5 (35.7)

13 (34.2)

0.626

17 (27.4)

13 (34.2)

0.472

NIHH score

Mild

25 (52.1)

7 (50)

17 (44.7)

0.729

32 (51.6)

17 (44.7)

0.338

Moderate

21 (43.8)

7 (50)

17 (44.7)

28 (45.2)

17 (44.7)

Severe

7 (4.2)

0 (0)

4 (10.5)

2 (3.2)

4 (10.5)

Duplex atherosclerotic scoring

Normal

7 (14.6)

5 (35.7)

9 (23.7)

0.335

12 (19.4)

9 (23.7)

0.614

Mild

25 (52.1)

4 (28.6)

15 (39.5)

29 (46.8)

15 (39.5)

Moderate

11 (22.9)

2 (14.3)

6 (15.8)

13 (21)

6 (15.8)

Severe

5 (10.4)

3 (21.4)

8 (21.1)

8 (12.9)

8 (21.1)

CRP levels

Normal ≤ 5 mg/L

6 (12.5)

3 (21.4)

23 (60.5)

 < 0.001*

9 (14.5)

23 (60.5)

 < 0.001*

Abnormal > 5 mg/L

42 (87.5)

11 (78.6)

15 (39.5)

53 (85.5)

15 (39.5)

Mean ± SD

26.60 ± 18.54

20.39 ± 20.11

8.34 ± 10.81

 < 0.001*

25.20 ± 18.92

8.34 ± 10.81

 < 0.001*

  1. DM Diabetes Mellitus, HTN hypertension, SD standard deviation, NIHSS National Institutes of Health Stroke Scale
  2. *p Value ≤ 0.05 is statistically significant